Selective NPY (Y5) antagonists

Details for Australian Patent Application No. 2004208715 (hide)

International Classifications

Event Publications

23 September 2004 Complete Application Filed

30 September 2004 Application Open to Public Inspection

Published as AU-A-2004208715

30 June 2005 Assignment before Grant

Novartis AG; Synaptic Pharmaceutical Corporation The application has been assigned to H. Lundbeck A/S; Novartis AG

2 February 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.